Simpler Grants.gov #PAR-26-132

NIA Forecasted Grant for Preclinical Drug Discovery in Alzheimer's and Related Dementias

This opportunity is a forecasted research grant from the National Institute on Aging (NIA) for Alzheimer's disease and related dementias (AD/ADRD): - Government Buyer: - National Institute on Aging (NIA), part of the National Institutes of Health - Scope of Work: - Preclinical drug target validation and early-stage drug discovery for AD/ADRD - Research may involve small molecules, biologics, and emerging therapeutic modalities - Products/Services Requested: - Research services focused on validating novel drug targets and discovering new therapeutic approaches for AD/ADRD - Eligibility and Participation: - Open to educational institutions, nonprofits, businesses, tribal organizations, and government entities - Notable Requirements: - No specific OEMs, vendors, or commercial products are named - Emphasis on rigorous, innovative research in the field of neurodegenerative disease drug discovery - Funding Instrument: - Cooperative agreement (grant) - Place of Performance: - National Institute on Aging (NIA)

Description

The National Institute on Aging (NIA) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications for research on Alzheimer's disease (AD) and AD-related dementias (ADRD) drug target validation and early-stage drug discovery against novel targets. This NOFO will support rigorous preclinical AD/ADRD drug target validation and early-stage drug discovery of small molecules, biologic, and emerging therapeutic modalities. Applications are not being solicited at this time; the notice is provided to allow potential applicants sufficient time to develop collaborations and responsive projects. Investigators with expertise in AD/ADRD and drug discovery are encouraged to consider applying for this new NOFO.

View original listing